Publication | Closed Access
Ferrocene‐modified thiopyrimidines: synthesis, enantiomeric resolution, antitumor activity
31
Citations
25
References
2010
Year
Medicinal ChemistryEnantiomeric ResolutionDerivativesChemoprevention StrategyAbstract Ferrocenylalkyl ThiopyrimidinesMedicineTumor Growth InhibitionOrganic ChemistryChemodynamic TherapyAnti-cancer AgentAlkyl FerrocenesHeterocycle ChemistryPharmacologyRadiation OncologyPharmaceutical ChemistryEnantioselective SynthesisDrug DiscoveryHealth Sciences
Abstract Ferrocenylalkyl thiopyrimidines ( 6a–d to 9a–d ) were prepared via the reaction of the α‐(hydroxy)alkyl ferrocenes, FcCHR(OH) ( 1a–d ; Fc = ferrocenyl; R = H, Me, Et, Ph), with 2‐thiopyrimidines ( 2 – 5 ) in acetone at room temperature in the presence of TFA, yielding 50–95%. The resulting enantiomers were resolved using HPLC on modified cellulose as chiral selector. The antitumor activities of S ‐ferrocenylethyl 2‐thiopyrimidine ( 6b ) against two murine solid tumor models, carcinoma 755 (Ca755) and Lewis lung carcinoma (LLC) were evaluated in vivo . The strong antitumor effect of compound 6b on Ca755 and LLC was demonstrated. The index of tumor growth inhibition on Ca755 equaled 95% in comparison with control. Copyright © 2010 John Wiley & Sons, Ltd.
| Year | Citations | |
|---|---|---|
Page 1
Page 1